CIBC Private Wealth Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,198
| Closed | -$363K | – | 1065 |
|
|
2021
Q2 | $363K | Sell |
2,198
-86,422
| -98% | -$14.4M | ﹤0.01% | 862 |
|
|
2021
Q1 | $13.6M | Sell |
88,620
-69,946
| -44% | -$9.5M | 0.03% | 302 |
|
|
2020
Q4 | $19.9M | Sell |
158,566
-3,235
| -2% | -$362K | 0.05% | 241 |
|
|
2020
Q3 | $16.4M | Sell |
161,801
-1,697
| -1% | -$173K | 0.05% | 232 |
|
|
2020
Q2 | $15.9M | Sell |
163,498
-8,603
| -5% | -$801K | 0.08% | 171 |
|
|
2020
Q1 | $14.3M | Sell |
172,101
-856
| -0.5% | -$83.5K | 0.06% | 204 |
|
|
2019
Q4 | $19.2M | Buy |
172,957
+883
| +0.5% | +$90.8K | 0.06% | 210 |
|
|
2019
Q3 | $17.1M | Sell |
172,074
-744
| -0.4% | -$73.9K | 0.06% | 220 |
|
|
2019
Q2 | $17.1M | Sell |
172,818
-761
| -0.4% | -$72.6K | 0.06% | 228 |
|
|
2019
Q1 | $19.1M | Sell |
173,579
-2,453
| -1% | -$256K | 0.07% | 201 |
|
|
2018
Q4 | $16.2M | Sell |
176,032
-787
| -0.4% | -$79.6K | 0.07% | 209 |
|
|
2018
Q3 | $19.5M | Buy |
176,819
+783
| +0.4% | +$81.5K | 0.07% | 214 |
|
|
2018
Q2 | $16.4M | Buy |
176,036
+6,065
| +4% | +$522K | 0.07% | 227 |
|
|
2018
Q1 | $14.1M | Buy |
169,971
+7,738
| +5% | +$688K | 0.06% | 243 |
|
|
2017
Q4 | $14.8M | Buy |
+162,233
| New | +$13.5M | 0.06% | 247 |
|
Other funds holding PRAH
CIBC Private Wealth Group's PRAH Position: Q3 2021 in Review
CIBC Private Wealth Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,198 shares — an estimated $363K sold.
CIBC Private Wealth Group first reported a position in PRAH in Q4 2017 and held it in 15 quarters. The position peaked at $19.9M in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- CIBC Private Wealth Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- CIBC Private Wealth Group sold 2,198 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $363K.
- CIBC Private Wealth Group first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 15 quarters.
- CIBC Private Wealth Group's PRA Health Sciences, Inc. position peaked at $19.9M in Q4 2020.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on CIBC Private Wealth Group's 13F filing for Q3 2021, filed 12 Nov 2021.